Longaeva Partners »

Relay Therapeutics shares owned by Longaeva Partners

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.7M 471k 9.95

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Relay Therapeutics

Sb Investment Advisers
Commodore Capital
Casdin Capital
BlackRock
Perceptive Advisors
Vanguard Group
Bellevue Group
Vanguard Capital Management
State Street Corporation
Nextech Invest
TCG Crossover Management
Geode Capital Management
Balyasny Asset Management
Dimensional Fund Advisors
Goldman Sachs Group

View all funds holding Relay Therapeutics